J9017 Insurance Policy Changes

HCPCS J9017 is officially defined as "Injection, arsenic trioxide, 1 mg." HCPCS J9017 is referenced in 3 tracked payer policy changes from Highmark and Humana. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J9017 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Related

All billing codesJ35909921399214992129920399202

Get alerts for changes like this

Save a search and receive a daily digest whenever a new policy change matches your filters.

Create a free alert